$CRTG
CORETEC GROUP INC.

2023 Q2 Form 10-Q Financial Statement

#000143774923014460 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $305.8K $347.2K $960.5K
YoY Change -30.2% -19.88% 249.65%
% of Gross Profit
Research & Development $121.4K $111.9K $135.3K
YoY Change -0.34% -43.62% 224.1%
% of Gross Profit
Depreciation & Amortization $23.04K $2.373K $23.03K
YoY Change 1.14% 2296.97% 11.47%
% of Gross Profit
Operating Expenses $121.4K $111.9K $1.091M
YoY Change -0.34% -43.62% 245.25%
Operating Profit
YoY Change
Interest Expense $52.85K $54.08K -$54.48K
YoY Change 11.38% 12.69% -0.06%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$474.3K -$507.4K -$1.145M
YoY Change -21.86% -25.31% 209.16%
Income Tax
% Of Pretax Income
Net Earnings -$474.3K -$507.4K -$1.145M
YoY Change -21.86% -25.31% 209.16%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 282.5M 268.9M 267.6M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.450M $1.943M $2.356M
YoY Change -53.29% -45.42% -41.87%
Cash & Equivalents $1.450M $1.943M $2.356M
Short-Term Investments
Other Short-Term Assets $31.48K $56.67K $114.2K
YoY Change -55.95% -46.41% -14.45%
Inventory
Prepaid Expenses $31.48K $56.67K $114.2K
Receivables
Other Receivables
Total Short-Term Assets $1.481M $2.000M $2.471M
YoY Change -53.35% -45.45% -40.99%
LONG-TERM ASSETS
Property, Plant & Equipment $110.1K $71.09K $73.46K
YoY Change 54.93% 1117.9%
Goodwill $166.0K $166.0K $166.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.550K $4.550K $4.550K
YoY Change 0.0% -93.42% -72.15%
Total Long-Term Assets $1.146M $1.128M $1.151M
YoY Change -3.66% -6.78% -1.79%
TOTAL ASSETS
Total Short-Term Assets $1.481M $2.000M $2.471M
Total Long-Term Assets $1.146M $1.128M $1.151M
Total Assets $2.628M $3.128M $3.622M
YoY Change -39.81% -35.86% -32.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $314.4K $345.2K $317.0K
YoY Change -29.05% -14.0% 3.22%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $30.90K $61.40K
YoY Change
Long-Term Debt Due $0.00 $67.74K $0.00
YoY Change
Total Short-Term Liabilities $314.4K $443.8K $378.4K
YoY Change -29.06% 10.58% 23.22%
LONG-TERM LIABILITIES
Long-Term Debt $1.447M $1.363M $1.415M
YoY Change 18.94% 13.4% 19.14%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.447M $1.363M $1.415M
YoY Change 18.94% 13.4% 19.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $314.4K $443.8K $378.4K
Total Long-Term Liabilities $1.447M $1.363M $1.415M
Total Liabilities $1.762M $1.807M $1.793M
YoY Change 6.13% 12.69% 19.98%
SHAREHOLDERS EQUITY
Retained Earnings -$17.33M -$16.85M -$16.35M
YoY Change 17.33% 19.01% 21.24%
Common Stock $56.63K $53.77K $53.77K
YoY Change 10.41% 5.19% 5.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $866.0K $1.321M $1.828M
YoY Change
Total Liabilities & Shareholders Equity $2.628M $3.128M $3.622M
YoY Change -39.81% -35.86% -32.42%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$474.3K -$507.4K -$1.145M
YoY Change -21.86% -25.31% 209.16%
Depreciation, Depletion And Amortization $23.04K $2.373K $23.03K
YoY Change 1.14% 2296.97% 11.47%
Cash From Operating Activities -$422.5K -$382.4K -$492.1K
YoY Change 8.46% -21.39% 61.97%
INVESTING ACTIVITIES
Capital Expenditures $41.37K $0.00 $0.00
YoY Change -161.43% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$41.37K $0.00 $0.00
YoY Change -38.57% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -29.65K -30.50K 72.38K
YoY Change
NET CHANGE
Cash From Operating Activities -422.5K -$382.4K -492.1K
Cash From Investing Activities -41.37K 0.000 0.000
Cash From Financing Activities -29.65K -30.50K 72.38K
Net Change In Cash -493.5K -$412.9K -419.7K
YoY Change 8.02% -16.14% 38.15%
FREE CASH FLOW
Cash From Operating Activities -$422.5K -$382.4K -$492.1K
Capital Expenditures $41.37K $0.00 $0.00
Free Cash Flow -$463.8K -$382.4K -$492.1K
YoY Change 43.98% -22.34% 61.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
433323 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1807154 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001375195
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
30900 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
61398 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
67742 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
69 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
268871202
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
53772 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18119792 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16852697 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1320936 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3128090 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
347194 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
54081 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
47990 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
513177 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y5M19D
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
679807 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5793 usd
CY2022Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
465 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-507384 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-679342 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.003
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
268871202
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
254932103
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1828320 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-507384 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1320936 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
70973 usd
CY2022Q1 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
17298 usd
CY2022Q1 crtg Stock Issued During Period Value Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-679342 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3273080 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-507384 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-679342 usd
CY2023Q1 us-gaap Depreciation
Depreciation
2373 usd
CY2022Q1 us-gaap Depreciation
Depreciation
99 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20658 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20657 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
16267 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14733 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
70973 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-57533 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-27751 usd
CY2023Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-0 usd
CY2022Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
52853 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
28169 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
111545 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-382384 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-486437 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5936 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
30498 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-412882 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-492373 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2356348 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4053327 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1943466 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3560954 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
33439 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
33298 usd
CY2023Q1 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
0 usd
CY2022Q1 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
180 usd
CY2023Q1 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
0 usd
CY2022Q1 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
17298 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<i>Use of Estimates</i>The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
254942697
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
235716997
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
30900 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
61398 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
67742 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
98642 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
61398 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1363351 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1187518 usd
CY2023Q1 crtg Amortization Associated With Commitment Fee
AmortizationAssociatedWithCommitmentFee
4337 usd
CY2022Q1 crtg Amortization Associated With Commitment Fee
AmortizationAssociatedWithCommitmentFee
3476 usd
CY2020Q2 crtg Share Exchange Agreement Number Of Options Authorized
ShareExchangeAgreementNumberOfOptionsAuthorized
21500000
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6 rate
CY2023Q1 crtg Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged
9500000
CY2023Q1 crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
5700000
CY2022 crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
5700000
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
132514000
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0555
CY2023Q1 crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P3Y4M18D
CY2023Q1 crtg Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
1333850 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
185933 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
77158160
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.070
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y5M19D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
77158160
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.070
CY2023Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
77158160
CY2023Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P3Y5M19D
CY2023Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
77158160
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
13650 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
4707 usd

Files In Submission

Name View Source Status
0001437749-23-014460-index-headers.html Edgar Link pending
0001437749-23-014460-index.html Edgar Link pending
0001437749-23-014460.txt Edgar Link pending
0001437749-23-014460-xbrl.zip Edgar Link pending
crtg-20230331.xsd Edgar Link pending
crtg20230331_10q.htm Edgar Link pending
ex_517897.htm Edgar Link pending
ex_517898.htm Edgar Link pending
ex_517899.htm Edgar Link pending
ex_517900.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
crtg-20230331_def.xml Edgar Link unprocessable
crtg-20230331_lab.xml Edgar Link unprocessable
crtg-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
crtg20230331_10q_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
crtg-20230331_cal.xml Edgar Link unprocessable